• Latest Posts

Gate Neurosciences emerges from stealth to tackle CNS diseases

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

Biogen’s New Drug Application for first treatment of rare form of neurological disease accepted by FDA

Trial for adults with late onset Pompe disease halted due to serious adverse event

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Sponsored by 22 Sep 2021

Discovering New Therapeutic Targets for Alzheimer’s Disease


AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

The Top European Biotech Funding Rounds in June

In Depth 12 May 2021

Spatial Transcriptomics: A Window into Disease

Top Neurotech Startups Unlocking the Brain in Russia

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation